Table 3.

Baseline characteristics of participants with screen-detected diabetes recruited to the ADDITION study (2001–2006), stratified by lipid-lowering therapy status

	Already on lipid-lowering therapy	No lipid-lowering therapy
n (%)	405 (14)	2,398 (86)
Age (years)	61.4 ± 6.0	59.5 ± 6.9**
BMI (kg/m2)	31.3 ± 5.2	31.7 ± 5.2
Total cholesterol (mmol/l)	4.9 ± 1.0	5.6 ± 1.1**
Total triacylglycerol (mmol/l)	2.2 ± 2.0	2.0 ± 1.4*
HDL-cholesterol (mmol/l)	1.2 ± 0.4	1.3 ± 0.4**
LDL-cholesterol (mmol/l)	2.8 ± 0.9	3.5 ± 1.0**

Data shown are mean ± SD, unless otherwise indicated

*p < 0.05 vs participants on lipid lowering therapy

**p < 0.001 vs participants on lipid lowering therapy